Kalingarayar Sriraam, Nandhakumar Amar, Thennavan Arumugam S
Department of Anaesthesiology, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India.
Department of Orthopaedics, Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India.
Indian J Anaesth. 2017 Dec;61(12):1009-1011. doi: 10.4103/ija.IJA_467_17.
The introduction of new chemotherapeutic agents for the treatment of multiple myeloma (MM) has improved the life expectancy and quality of life for these patients in the last decade. Therefore, more patients with MM are being treated for repeated pathological fractures. The anaesthesiologist should continue the optimum supportive care received by these patients in the perioperative period also, by understanding the pathophysiology of the disease, the adverse effects of the chemotherapeutic agents and the guidelines for their supportive care. We report the perioperative management of a patient with MM and discuss the perioperative anaesthetic considerations.
在过去十年中,用于治疗多发性骨髓瘤(MM)的新型化疗药物的引入提高了这些患者的预期寿命和生活质量。因此,越来越多的MM患者因反复发生病理性骨折而接受治疗。麻醉医生还应通过了解该疾病的病理生理学、化疗药物的不良反应及其支持治疗指南,在围手术期继续为这些患者提供最佳的支持治疗。我们报告了一例MM患者的围手术期管理,并讨论围手术期的麻醉注意事项。